ASMB
Assembly Biosciences Inc
NASDAQ · Biotechnology
$26.22
+0.83 (+3.27%)
Open$25.62
Previous Close$25.39
Day High$26.80
Day Low$25.58
52W High$39.71
52W Low$7.75
Volume—
Avg Volume95.0K
Market Cap414.73M
P/E Ratio—
EPS$-4.81
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
-58.4% upside
Current
$26.22
$26.22
Target
$10.92
$10.92
$9.01
$10.92 avg
$17.95
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 75.13M | 45.30M | 303.48M |
| Net Income | -105,834,062 | -57,438,735 | 8.79M |
| Profit Margin | -140.9% | -133.8% | 2.9% |
| EBITDA | -119,305,520 | -68,347,249 | 16.60M |
| Free Cash Flow | — | — | 12.57M |
| Rev Growth | +65.8% | +65.8% | +10.9% |
| Debt/Equity | — | — | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |